Deutsche Bank Aktiengesellschaft »

Fibrobiologics shares owned by Deutsche Bank Aktiengesellschaft

Quarter-by-quarter ownership of Fibrobiologics (FBLG) shares owned by Deutsche Bank Aktiengesellschaft from 13F filings

Historical chart of Deutsche Bank Aktiengesellschaft investment in Fibrobiologics

Tip: Access up to 7 years of quarterly data

All positions including Fibrobiologics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fibrobiologics by Deutsche Bank Aktiengesellschaft

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.4k 679 4.99

More positions owned by Deutsche Bank Aktiengesellschaft

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Merck & Co (MRK)
Visa Com Cl A (V)
Johnson & Johnson (JNJ)
UnitedHealth (UNH)
Adobe Systems Incorporated (ADBE)
Qualcomm (QCOM)

View all positions for Deutsche Bank Aktiengesellschaft

Top funds holding Fibrobiologics

BlackRock
State Street Corporation
Geode Capital Management
Cascade Financial Partners
Vanguard Group
Requisite Capital Management
American Institute for Advanced Investment Management
Bank of America Corporation
Bank of New York Mellon
Charles Schwab Investment Management
RMR Wealth Builders
Concurrent Investment Advisors
Nuveen Asset Management
ERn Financial
Ethos Financial Group

View all funds holding Fibrobiologics